|
FY2021
12 months to Dec 31, 2021
|
FY2020
6 months to Dec 31, 2020
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net Income (Loss) | ||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Interest earned on marketable securities held in Trust Account | ||
| Transaction costs associated with warrant liability | ||
| Change in fair value of warrant liability | ||
| Prepaid expense | ||
| Accrued expense | ||
| Net cash provided (used) in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment of cash in Trust Account | ||
| Net cash provided (used) in investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from sale of Units, net of underwriting discounts paid | ||
| Proceeds from sale of Private Placement Warrants | ||
| Payment of offering costs, net | ||
| Proceeds – Loan from Sponsor | ||
| Net cash provided (used) in financing activities | ||
| Net Change in Cash | ||
| Cash - July 16, 2021 (inception) | ||
| Cash - Ending | ||
| Initial classification of common stock subject to possible redemption | ||
| Change in value of common stock subject to possible redemption | ||
| Offering costs paid by Sponsor in exchange for issuance of founder shares | ||
| Cash – Beginning | ||
| Cash – December 31, 2021 | ||
| Non-Cash investing and financing activities: | ||
| Deferred Underwriting Fee Payable |
Loading...
